“The reality is that over the past five decades thousands of peer-reviewed articles, studies and reports have been published about the efficacy of Cold Lasers as part of certain treatment regimens,” said Kevin Waller, COO and co-founder of LumaCare.
SALT LAKE CITY and LAS VEGAS (PRWEB)
January 06, 2020
After 32 years in Stealth Mode, LumaCare™ emerged today to announce its formation and unveil its first product: The LumaCare Duo™.
The first public demonstrations of the LumaCare Duo will be given in the LumaCare booth (#44868) in the Sands Convention Center in Las Vegas, Nevada during CES 2020, the largest consumer electronics trade show and conference in the United States. Additionally, LumaCare will preview the LumaCare Duo from 7—10:30pm tonight to credentialed journalists, analysts, and influencers during the PEPCOM Digital Experience! press event at the Mirage Hotel Events Center on the Las Vegas Strip.
The LumaCare Duo is a handheld, wireless, and rechargeable “Cold Laser” device that features two rotating emitter heads, one each at opposite ends of jointed arms, to offer nearly 180 degrees of motion for delivering three different pulsating spectrums of therapeutic light to injured body parts. Each emitter head has a peak combined power output of 60 Watts from the 15 laser diodes and LEDs, specifically:
-
Four Infrared laser diodes at 905nm (nanometer wavelengths), - Six Infrared laser diodes at 808nm, and
- Five visible Red LEDs at 670nm, for a total of 30 laser diodes/LEDs per LumaCare Duo system.
Because the patent pending LumaCare Duo features two articulating emitter heads affixed to the ends of two movable arms, users can manipulate the device to direct therapeutic laser light at injured tissue from two directions at the same time. Additionally, having two emitter heads also allows LumaCare Duo users to focus more Infrared and visible Red light over a wider area if needed. Users may also choose to implement only one emitter head if that is what the treatment protocol requires.
BACKGROUND INFO ON LUMACARE AND “COLD LASER” THERAPIES
LumaCare is the brainchild of National Laser Company, a 32-year-old company focused on the industrial, commercial and medical laser marketplace, a firm that has primarily worked behind the scenes as a private label and/or original equipment manufacturer (OEM) and service provider to other laser companies.
Given this foundation of over 30 years of laser industry experience and expertise, the executive team at LumaCare is very familiar with the role of Cold Lasers / Low-Level Laser Therapy (LLLT) as a treatment protocol for a wide variety of chronic and traumatic injuries.
“The reality is that over the past five decades thousands of peer-reviewed articles, studies and reports have been published about the efficacy of Cold Lasers as part of certain treatment regimens,” said Kevin Waller, COO and co-founder of LumaCare. “In fact, the very first inkling of the potential therapeutic benefits of LLLT came in 1967 when Endre Mester discovered that treatments of Cold Laser light regrew hair on mice.
“Studies in the ensuing 50-plus years have shown particular benefit from three wavelength bandwidths: from 650—675nm for surface/skin-level treatments, from 800—825nm for medium depth treatments, and from 900—925nm for deeper tissue/joint treatments. Since Dr. Mester’s finding, hundreds of thousands of Cold Laser systems have been used to improve blood flow, boost oxygenation, reduce inflammation and pain, and enhance cellular recovery for traumatic and chronic injuries.”
MORE LUMACARE DUO DETAILS, PRICING AND AVAILABILITY
The LumaCare Duo weighs 10.75 ounces, measures 4.75- x 5.63- x 2.75-inches (height x width x depth) when folded/closed and 3.25- x 11.50- x 2.75-in. when fully open, while the emitter heads measure 2.1- x 2.7- x 0.6-in. The range of motion of the LumaCare Duo is ~90 degrees per arm and ~135° per emitter head, with a total range of motion of ~180° when the device is fully open.
The LumaCare Duo is classified by the U.S. Food and Drug Administration as a Class 1 laser and is expected to have a suggested retail price of under $3,000.00 (US). However, the LumaCare Duo is currently in the latter stages of review by the FDA, with 510K Clearance anticipated by LumaCare in early 2020.
As a result, the LumaCare Duo is not available for purchase or resale at this time.
Nevertheless, fully functioning LumaCare Duo units are available now for evaluation purposes by healthcare professionals, credentialed journalists, and other qualified individuals and organizations.
For more information, please contact LumaCare at 801-924-8791 or via email at info@LumaCareLasers.com.
Relevant Hashtags: #LumaCare #LumaCareDuo #ces #CES2020 #medtech #healthtech #ColdLasers #CoolLaser #laser #lasertech #healthcare #medical #medicine #treatment
LumaCare and LumaCareDuo are trademarks of LumaCare.
CONTACT:
David Politis, LumaCare’s VP of Marketing & Sales, 801-556-8184 (cell), dpolitis@LumaCareLasers.com
Share article on social media or email: